Apollon Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$418K Buy
1,565
+208
+15% +$56.3K 0.01% 947
2025
Q4
$340K Buy
1,357
+145
+12% +$38.5K 0.01% 1008
2025
Q3
$348K Buy
1,212
+405
+50% +$109K 0.01% 988
2025
Q2
$212K Sell
807
-260
-24% -$63.3K ﹤0.01% 1151
2025
Q1
$248K Sell
1,067
-18
-2% -$4.37K 0.01% 1024
2024
Q4
$249K Buy
+1,085
New +$249K 0.01% 1013
2020
Q3
Sell
-3
Closed 452
2020
Q2
$0 Buy
+3
New +$415 ﹤0.01% 750

Other funds holding LH

Apollon Wealth Management's LH Position: Q1 2026 in Review

Apollon Wealth Management increased its Labcorp (LH) stake by 15% in Q1 2026, buying an estimated $56.3K and bringing the position to 1,565 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #947.

Apollon Wealth Management first reported a position in LH in Q2 2020 and has held it in 7 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Apollon Wealth Management held 1,565 shares of Labcorp worth $418K as of Q1 2026.
  • Apollon Wealth Management bought 208 Labcorp shares in Q1 2026, an estimated $56.3K.
  • Labcorp made up 0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #947 holding.
  • Apollon Wealth Management first reported a position in Labcorp in Q2 2020 and has held it in 7 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.